ICICI Bank Limited (0A7M)
London Exchange · UK · prices in USD · close of 21 Oct 2026
Key indicators
| Last close | USD 29.54 |
|---|---|
| 52-week range | 24.36 – 32.73 |
| Return, 1 month / 3 months | +5.4% / −0.3% |
| Return, 1 year / 3 years | −4.6% / +33.1% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 21.9% |
| Worst drawdown (1 year) | -22.1% |
| Average daily value traded | 0.09M USD |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ICICI Bank is a private-sector bank based in Mumbai, India. It serves individual customers and businesses through retail banking such as savings and current accounts, home and personal loans, and cards, alongside corporate and small-business lending, trade finance and treasury services. Its group also includes insurance and asset management businesses. Customers are mainly in India, with additional operations abroad serving non-resident Indians and corporate clients.
ICICI Bank Limited trades under the code 0A7M on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ICICI Bank Limited (0A7M) trades on the London Exchange in UK. It last closed at USD 29.54 on 21 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,874 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.6% and over the last three months it fell 0.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.2% | ||
| From 52-week high | -8.9% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -0.3% | ||
| 6-month return | 2.1% | ||
| 12-month return, skipping the last month | -9.5% | ||
| Stability (higher is calmer) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.1% | ||
| Liquidity | 30 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.09M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 42 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.0% |
|---|---|
| 1 month | +5.4% |
| 3 months | −0.3% |
| 6 months | +2.1% |
| 1 year | −4.6% |
| 3 years | +33.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 28.85 / 28.62 |
|---|---|
| Golden / death cross (60 days) | Golden, 46 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.68 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Aug 2026 | INR 0.2120 |
| 12 Aug 2025 | INR 0.2186 |
| 12 Aug 2024 | INR 0.2028 |
| 8 Aug 2023 | INR 0.1737 |
| 9 Aug 2022 | INR 0.1119 |
| 28 Jul 2021 | INR 0.0487 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.